OK, if
The costs are pretty clear.
I'll be clearer, what are the normal costs that Big Biopharma spend to get one idea to the end of a Phase 3 trial, versus what Mesoblast has spent for 3? That would seem to be a fairly important answer for your credibility if you actually believe $500m is an over spend to get 3 to that point.
And how much do Big Pharma spend to get a cellular medicine candidate to the end of Phase 3 in the USA?
OK, ifThe costs are pretty clear. I'll be clearer, what are the...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.080(7.37%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $15.66M | 13.44M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 29235 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 182909 | 9 |
View Market Depth
| Last trade - 15.12pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
0.080 ( 7.93 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3093454 | ||
| Last updated 15.30pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |